Skip to main content
. Author manuscript; available in PMC: 2013 Apr 5.
Published in final edited form as: Biomaterials. 2012 Jun 9;33(26):6186–6193. doi: 10.1016/j.biomaterials.2012.05.029

Figure 1. NIRF imaging of small-sized HT29 colon tumors.

Figure 1

(a) Whole body images of athymic nude mice bearing HT29 tumors after intravenous injection of Cy5.5-P-HA-NPs as a function of time. Arrows indicate the sites of tumors. (b) Intravital fluorescence images of tumor vasculature and Cy5.5-P-HA-NPs. (c) Quantification of the NIRF intensities in the whole bodies and tumor tissues were estimated from the mean fluorescence intensities in 1000 mm2 for whole bodies and in 25 mm2 for the tumor tissues. Error bars represent the standard deviation (n=3). (d) Ex vivo fluorescence images of organs and tumor excised at 48 h post-injection of NPs (5mg/kg).

HHS Vulnerability Disclosure